Quantcast
Last updated on April 16, 2014 at 13:56 EDT

Latest glioblastoma multiforme Stories

2013-05-23 08:28:11

NW Bio Exhibit Will Describe DCVax Technology and Clinical Trial Progress at Annual Meeting of Over 25,000 Oncologists BETHESDA, Md., May 23, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that it will use its exhibit at this year's American Society Of Clinical Oncology (ASCO) meeting in Chicago to highlight its leadership role in immune...

2013-05-20 08:27:14

SAN DIEGO, May 20, 2013 /PRNewswire/ -- TRACON Pharmaceuticals, a biopharmaceutical company that develops targeted therapies for oncology and ophthalmology, today announced multiple clinical investigations for TRC105 and the presentation of two abstracts at the 49(th) Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 31 to June 4 in Chicago. TRC105, a novel monoclonal antibody to endoglin (CD105), is being studied in multiple clinical trials in combination with...

2013-05-20 08:27:01

VANCOUVER, Canada and MENLO PARK, Calif., May 20, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) announced today that Jeffrey Bacha, president and CEO, will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. The Company's presentation is scheduled to begin at 11:30 a.m. EDT and will be available via a live webcast. To access the webcast, go to:...

2013-05-16 08:28:37

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha: During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer clinical trial. Our current trial is a dose-escalating study designed to evaluate the safety and efficacy of VAL-083 as a potential treatment for...

2013-05-16 08:28:24

Up To 30 European Sites To Join 46 Active Sites In The US BETHESDA, Md., May 16, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®)-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax(®)-L for brain cancer has been initiated at King's College Hospital in the UK. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO) This is one of the...

2013-05-15 10:32:53

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy. Recently published in the journal Clinical Cancer Research, the study provides the first preclinical evidence demonstrating that an ATM kinase...

2013-05-07 08:32:59

ST. HELIER, Jersey, May 7, 2013 /PRNewswire/ -- Novocure announced today that the EF-14 pivotal clinical trial for patients with newly diagnosed glioblastoma (GBM) brain tumors has enrolled its first patient in Korea. This randomized, controlled trial is designed to enroll approximately 700 patients and will test the efficacy and safety of NovoTTF(TM) Therapy when added to the current best standard of care for newly diagnosed GBM. NovoTTF Therapy is delivered by a portable, non-invasive...

2013-05-04 23:01:53

Voices Against Brain Cancer, an organization dedicated to brain tumor research and advocacy, congratulates Alec Panici on being recognized as Caregiver of the Year. New York, NY (PRWEB) May 04, 2013 On May 4, Voices Against Brain Cancer, an organization dedicated to brain tumor research and advocacy, congratulates 24-year old Alec Panici on being recognized as Caregiver of the Year this upcoming Sunday, May 5th, at the Join The Voices! Run/Walk being held in Chicago. Alec Panici´s...

2013-05-03 23:18:19

Voices Against Brain Cancer, an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help in diagnosing and treating certain pediatric brain tumor cases. New York, NY (PRWEB) May 03, 2013 On May 3, Voices Against Brain Cancer (VABC), an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help doctors in classifying and treating certain pediatric brain tumors....

2013-05-03 16:22:21

BETHESDA, Md., May 3, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today the availability on the web of several interviews of their CEO Linda Powers on the floor of the New York Stock Exchange on May 1, 2013 by FOX Business News (FOX), the Huffington Post, and the International Business Times, amongst others. (Logo:...